Anxiety News and Research

Latest Anxiety News and Research

Investigating post-COVID complaints after Delta versus Omicron variant infections

A new study discusses whether infection with the SARS-CoV-2 Omicron variant increases the risk of post-COVID complaints Delta infection.

30 May 2022

Medical cannabis use shown to improve cancer-related symptoms in new study

Researchers describe the effectiveness and safety of medical cannabis use for treating cancer-related symptoms.

30 May 2022

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Researchers discuss changes in depressive and anxiety symptoms during the COVID-19 pandemic.

30 May 2022

Neurological symptoms may persist for over one year in long-COVID patients

Patients who have recovered from COVID-19 are likely to experience persistent neurologic symptoms for a median of 14.8 months following their initial infection.

30 May 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

Autistic adults have worse health and poorer quality healthcare

Autistic individuals are more likely to have chronic mental and physical health conditions, suggests new research from the University of Cambridge. Autistic individuals also report lower quality healthcare than others.

27 May 2022

FDA grants Breakthrough Device designation for Emily's Care Nourish Test System

Lactation Lab, which offers the most scientifically advanced breast milk testing available, has announced today that the U.S. Food and Drug Administration, has granted the company Breakthrough Device designation for its latest device Emily's Care Nourish Test System that tests and provides a nutritional analysis of breast milk.

26 May 2022

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

Researchers evaluated the incidence of post-COVID-19 conditions among adults in the United States.

26 May 2022

The frequency, nature, determinants, and impact of long-COVID in Scotland

Researchers evaluated long-term sequelae of COVID-19 in Scotland.

26 May 2022

Key immunological changes that support peanut allergy remission in children discovered

Australian researchers have discovered the key immunological changes that support the remission of peanut allergy in children, paving the way for new, more targeted treatments.

25 May 2022

Online tool accurately predicts the likelihood for post-operative ICU need

Even before the COVID-19 pandemic, intensive care unit (ICU) beds were in limited supply, and the pandemic only exacerbated this growing concern.

25 May 2022

The root causes of long-COVID still a mystery

In a recent article posted to the journal Annals of Internal Medicine, researchers presented baseline outcomes from a longitudinal assessment of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), also known as long-COVID.

25 May 2022

Correlation between long-COVID and physical inactivity

In a recent study under review at the Scientific Reports journal and posted to the Research Square* preprint server, researchers assessed whether physical inactivity in coronavirus disease 2019 (COVID-19) survivors led to the development of post-acute sequelae of COVID-19 (PASC), also known as long-COVID.

25 May 2022

Study: Nearly one-quarter of young sarcoma patients continue to use opioids after treatment completion

New analysis finds more than half of U.S. adolescents and young adults with sarcoma-;a type of cancer in the bones or soft tissues-;are often prescribed opioids to treat their pain.

23 May 2022

Adventurous play may help prevent mental health problems in children

Children who spend more time playing adventurously have lower symptoms of anxiety and depression, and were happier over the first Covid-19 lockdown, according to new research.

20 May 2022

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

James Bibb, Ph.D., and colleagues have described a novel preclinical drug that could have the potential to combat depression, brain injury and diseases that impair cognition. The drug, which notably is brain-permeable, acts to inhibit the kinase enzyme Cdk5.

20 May 2022

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

A comprehensive assessment of the benefits of medical cannabis for cancer-related pain found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.

20 May 2022

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a new study from Massachusetts General Hospital finds that treating psychiatric disorders with psychotropic medications in children and adolescents does not increase the risk of developing substance use, misuse, or substance use disorder (SUD).

19 May 2022

Psychological risk factors may increase chances of hospitalization after COVID-19 diagnosis

People who reported in a survey that they felt worried, depressed or lonely had a greater chance of being hospitalized after a COVID-19 diagnosis, suggests a study funded by the National Institutes of Health.

19 May 2022

Do people experience more anxiety, depression and distress after COVID?

A recent study posted to the medRxiv* preprint server analyzed mental health outcomes after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

18 May 2022

Anxiety News and Research

Latest Anxiety News and Research

Investigating post-COVID complaints after Delta versus Omicron variant infections

Medical cannabis use shown to improve cancer-related symptoms in new study

Increase in depression and anxiety rates in the U.K. identified during COVID-19 lockdowns

Neurological symptoms may persist for over one year in long-COVID patients

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Autistic adults have worse health and poorer quality healthcare

FDA grants Breakthrough Device designation for Emily's Care Nourish Test System

The incidence of post-COVID conditions among patients who had received a previous COVID-19 diagnosis

The frequency, nature, determinants, and impact of long-COVID in Scotland

Key immunological changes that support peanut allergy remission in children discovered

Online tool accurately predicts the likelihood for post-operative ICU need

The root causes of long-COVID still a mystery

Correlation between long-COVID and physical inactivity

Study: Nearly one-quarter of young sarcoma patients continue to use opioids after treatment completion

Adventurous play may help prevent mental health problems in children

Novel brain-permeable Cdk5 inhibitor alters neurobehavior in mice

Medicinal cannabis can be considered as alternative to pain relief medicines for cancer patients

Treating pediatric psychiatric disorders with psychotropic drugs reduces later substance use disorder risk

Psychological risk factors may increase chances of hospitalization after COVID-19 diagnosis

Do people experience more anxiety, depression and distress after COVID?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Anxiety News and Research

Latest Anxiety News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in